STOCK TITAN

GALEXXY HLDGS INC - GXXY STOCK NEWS

Welcome to our dedicated page for GALEXXY HLDGS news (Ticker: GXXY), a resource for investors and traders seeking the latest updates and insights on GALEXXY HLDGS stock.

Galexxy Holdings Inc. (OTC PINK: GXXY) is a diversified company with a focus on emerging markets. They have expanded their strategic commercial supply and lease agreements, marketing programs, and installations of smart kiosks. The company works closely with Delta 88 and uVending, aiming to generate substantial revenues in the coming years. Galexxy is known for its innovative geospatial advertising solutions and proprietary products, driving foot traffic and sales through VendGenie Smart Kiosks.

Recently, Galexxy has appointed Trent D'Ambrosio as the Vice President of Sales and Marketing. With a successful background in executive business management and sales, Trent is expected to drive rapid sales revenue growth and expand retail and wholesale sales programs. Galexxy is set to launch the Galexxy Sales App, integrating Verb and Hussle technologies, to empower sales leaders and scale sales organizations through advanced features like live streaming, training, and one-click sampling.

The company is redirecting its focus to the Functional Mushroom Market and direct-selling industry, anticipating substantial growth and positioning themselves as industry leaders. Galexxy is dedicated to revolutionizing the health and wellness sector with innovative products and technology-driven solutions, all aimed at maximizing shareholder value and ensuring long-term sustainability.

Funding Adaptin, a new venture in the wellness market, Galexxy Holdings aims to tap into the growing adaptogen market and provide innovative products with transparent compensation plans. With a visionary leadership team and a strategic approach, Adaptin is set to offer unique opportunities to health and wellness enthusiasts and brand advocates, driving innovation and growth in the direct sales landscape.

Rhea-AI Summary

Adaptin, a new wellness brand, announced its launch on June 25, 2024, aiming to bring functional adaptogens and nootropics to a global audience through innovative marketing strategies. The US adaptogen and functional mushroom supplements market was valued at $40 billion in 2023, part of the $5.7 trillion global wellness market. The brand offers products like natural and organic gummies and elixirs designed to combat anxiety, stress, lack of sleep, and focus issues. Adaptin's proprietary 100-day extraction process ensures high-quality blends. The company plans a preview in Q3 2024 and a full launch in October 2024, with opportunities for early access and profit-sharing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.04%
Tags
none
-
Rhea-AI Summary

Galexxy Holdings (OTC PINK:GXXY) has elected Tyler Whitehead to its board of directors. Whitehead is the co-founder and CEO of Adaptin, former CEO of Arbonne, and was President for Nu Skin Enterprises. Over 20 years, he has driven growth in the wellness sector, with experience in global markets, innovation, and legal and risk management. His recent role at Arbonne involved transforming the brand through digital and sustainable business models. Whitehead aims to leverage his expertise to expand Galexxy's reach in the $4.6 trillion global wellness market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
29.82%
Tags
management
-
Rhea-AI Summary

Galexxy Holdings Inc. announces the creation of a new company, Adaptin, , focusing on the functional mushroom and adaptogen market. Adaptin aims to tap into the rapidly growing $32B global market by offering innovative products and business models. Tyler Whitehead is appointed as CEO and Co-Founder, with Galexxy maintaining a 56.5% ownership stake. The partnership aims to drive innovation, expand globally, and enhance customer engagement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.17%
Tags
none
Rhea-AI Summary
Galexxy Holdings Inc. redirects resources to the Functional Mushroom Market, divesting from CBD and Hemp businesses. The company positions itself to capitalize on the growing demand for functional mushrooms, focusing on Wellbeing Farms and Galexxy LLC. Galexxy plans to expand in the direct-selling market, aiming for long-term sustainability and shareholder value maximization.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.45%
Tags
none
-
Rhea-AI Summary
Galexxy Holdings Inc. and Hussle.Tech have agreed to integrate the Verb and Hussle app technologies with the new Galexxy Sales App to power the Galexxy direct sales channel. The new app is expected to bring new revenues through increased clicks to the website and engagement. Galexxy aims to create a new $69 billion marketplace by 2030. The integration of Hussle technology will provide tools for building individual businesses, communication, training, and more. Galexxy's leaders will have new functional mushroom products to sell backed by real-time payment recognition and billing technology. The targeted pre-launch is scheduled for this quarter.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
34.94%
Tags
none
-
Rhea-AI Summary
Galexxy Holdings announces the appointment of Trent D'Ambrosio as VP of Sales and Marketing, aiming to expand retail and wholesale sales programs. Trent's leadership experience is expected to drive rapid sales growth and open new distribution channels. Galexxy's CEO expresses enthusiasm for Trent's appointment. Trent highlights the potential growth in the health and wellness industry and sees Galexxy as an excellent fit with emerging global market trends. Galexxy's shares are publicly traded on OTC Markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.57%
Tags
none
Rhea-AI Summary
VendGenie expands agreement with Delta 88, revenue forecast increased to $12.75m in year two
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.14%
Tags
none
-
Rhea-AI Summary
Galexxy Holdings outlines forecasted revenue sources for 2024, including $7.5m from Wellbeing Farms, $10m from Galexxy LLC, and $3m from VendGenie's agreement with Delta 88. ABC Holdings anticipates a 2x increase in AVALOO sales revenue. Galexxy LLC specializes in direct-to-consumer sales of functional mushroom supplements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.73%
Tags
none
-
Rhea-AI Summary
Galexxy Holdings signs joint venture with Pillars International, introducing new Direct Sales Company called Galexxy LLC. Ambassadors will sell functional mushroom products with new payment and billing platform. Targeted pre-launch this 4th quarter. Galexxy has controlling interest in Galexxy LLC. Positive opportunity in the market. Joint venture caught interest of key leaders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.42%
Tags
none

FAQ

What is the current stock price of GALEXXY HLDGS (GXXY)?

The current stock price of GALEXXY HLDGS (GXXY) is $0.0065 as of December 23, 2024.

What is the market cap of GALEXXY HLDGS (GXXY)?

The market cap of GALEXXY HLDGS (GXXY) is approximately 2.8M.

Who is Trent D'Ambrosio and what role does he play at Galexxy Holdings?

Trent D'Ambrosio is the Vice President of Sales and Marketing at Galexxy Holdings. With a successful background in executive business management and sales, Trent leads the sales strategy and execution, focusing on expanding retail and wholesale sales programs.

What is the Galexxy Sales App and how does it benefit sales leaders?

The Galexxy Sales App integrates Verb and Hussle technologies to empower sales leaders with advanced features like live streaming, training, and one-click sampling. It enables rapid scaling of sales organizations and drives engagement and sales growth.

How is Galexxy Holdings repositioning its focus in the market?

Galexxy Holdings is redirecting its resources to the Functional Mushroom Market and direct-selling industry, anticipating substantial growth and positioning themselves as industry leaders. The company is committed to revolutionizing the health and wellness sector with innovative products and technology-driven solutions.

What is Adaptin, and how does it contribute to Galexxy Holdings' growth strategy?

Adaptin is a new company founded by Galexxy Holdings in the wellness market, focusing on the adaptogen market. With a strategic approach and transparent compensation plans, Adaptin offers unique opportunities to health and wellness enthusiasts and brand advocates, driving innovation and growth in the direct sales landscape.

What are the future plans of Galexxy Holdings in terms of market expansion?

Galexxy Holdings aims to tap into the growing adaptogen market through Adaptin and consolidate its position in the Functional Mushroom Market and direct-selling industry. The company is dedicated to providing innovative products and technology-driven solutions, maximizing shareholder value, and ensuring long-term sustainability.

GALEXXY HLDGS INC

OTC:GXXY

GXXY Rankings

GXXY Stock Data

2.79M
187.45M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Newport Beach